News
Important Only
iHeartMedia Inc reports results for the quarter ended December 31 - Earnings Summary
iHeartMedia Inc IHRT.OQ reported quarterly adjusted earnings of 22 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of five analysts for the quarter was for earnings of 37 cents per share. Wal...Reuters
Thu, Feb 27
GLOBAL MARKETS-Wall Street ends lower, as tariff risk rattles European shares
Updated at 4:30 p.m. ET (2130 GMTEuropean shares close down 0.5%, following Wednesday's record Wall Street under pressure from weak US data, tech lossesGold hits a 2-week low on a firmer dollarBy Chris Prentice and Greta Rosen Fondahn NEW YORK/GDANSK, Feb 27 (Reuters) - Major Wall Street inde...Reuters
Thu, Feb 27
Monster Beverage Achieves Record Revenue
Monster Beverage (NASDAQ:MNST), renowned for its energy drink offerings, released its fourth-quarter 2024 earnings on February 27, 2025. The earnings report showed a mixed performance, with net sales achieving a record $1.81 billion, exceeding the $1.79 billion analyst estimate. However, the company...The Motley Fool
Thu, Feb 27
Erie Indemnity's profit jumps on robust fees, investment income
Feb 27 (Reuters) - Erie Indemnity's ERIE.O fourth-quarter profit rose 37% as it earned higher fees from policies and bigger returns on its investments, the property and casualty insurer said on Thursday.Policyholders encouraged by a resilient economy have maintained high insurance spending and o...Reuters
Thu, Feb 27
Redfin Revenue Rises, EPS Lags Behind
Redfin (NASDAQ:RDFN), a technology-centered real estate brokerage, released its earnings for the fourth quarter of 2024 on Feb. 27, 2025. Significant revenue growth was the highlight, reaching $244.3 million, which outpaced analyst expectations of $242 million, and marked a 12.0% increase compared t...The Motley Fool
Thu, Feb 27
Celldex Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Celldex Therapeutics Inc CLDX.OQ reported a quarterly adjusted loss of 71 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -83 cents. The mean expectation of twelve analysts for the quarter was for a loss of 73 cents per s...Reuters
Thu, Feb 27
MORNING BID ASIA-Tariffs, tech fatigue rev up month-end turbulence
We're excited to announce that Morning Bid Asia will be rebranded as Trading Day as of March 3. It's not just the title that's changing. We're enhancing the newsletter to offer you more in-depth analysis and insightful commentary on global markets from Jamie McGeever, Reuters' ma...Reuters
Thu, Feb 27
Nvidia's optimistic forecast fails to convince Wall Street
'Magnificent Seven' tech stocks continue to struggleNvidia expects total revenue of $43 billion for Q1Changes headline, recasts paragraphs 1-4, updates share priceBy Arsheeya Bajwa Feb 27 (Reuters) - Wall Street took a dim view of Nvidia's NVDA.O quarterly forecast on Thursday wit...Reuters
Thu, Feb 27
Spyre Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Spyre Therapeutics Inc SYRE.OQ reported a quarterly adjusted loss of 81 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-4.05. The mean expectation of eleven analysts for the quarter was for a loss of 99 cents per share....Reuters
Thu, Feb 27
PubMatic EPS Beats, Revenue Falls Short
PubMatic (NASDAQ:PUBM), a key player in the digital advertising technology space, recently released its earnings for Q4 2024 on February 27, 2025. The company reported a Non-GAAP EPS of $0.41, which exceeded analyst expectations of $0.23. However, revenue of $85.5 million fell short of both analyst ...The Motley Fool
Thu, Feb 27
BUZZ-Autodesk rises on stronger profit forecast for fiscal 2026
** Shares of software firm Autodesk ADSK.O climb 7.7% to $304 after the close** Company sees fiscal 2026 profit of $9.34-$9.67 per share, higher than estimate of $9.24/share — LSEG** Reports strong growth in design and subscription plan revenue in the fourth quarter** "Autodesk is focused on the...Reuters
Thu, Feb 27
Denali Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Denali Therapeutics Inc DNLI.OQ reported a quarterly adjusted loss of 67 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -86 cents. The mean expectation of eighteen analysts for the quarter was for a loss of 80 cents per ...Reuters
Thu, Feb 27
Geo Group (GEO) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.Geo Group (NYSE: GEO)Q4 2024 Earnings CallFeb 27, 2025, 11:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to The GEO Group fourth quarter 2024 earnings conference call. All participants will...The Motley Fool
Thu, Feb 27
Medical Properties Trust (MPW) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.Medical Properties Trust (NYSE: MPW)Q4 2024 Earnings CallFeb 27, 2025, 11:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning everyone, and welcome to the Q4 2024 Medical Properties Trust earnings confer...The Motley Fool
Thu, Feb 27
Arista Networks Sank Today -- Is It Time to Buy the Stock?
Arista Networks (NYSE: ANET) stock ended Thursday's trading in the red. The networking technologies company's share price had been up as much as 1.8% early in the day's trading, but it lost ground as the market soured on Nvidia's fourth-quarter earnings report.Arista stock closed out the day down 5%...The Motley Fool
Thu, Feb 27
US STOCKS-S&P 500 ends down as Nvidia tumbles following report
Snowflake surges on upbeat 2026 product revenue forecastSalesforce falls on downbeat annual revenue forecastUS weekly jobless claims rise more than expectedS&P 500 -1.59%, Nasdaq -2.78%, Dow -0.45%Updates with details after end of tradingBy Noel Randewich and Johann M Cherian Feb 26 (Reuters)...Reuters
Thu, Feb 27
Ligand Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Ligand Pharmaceuticals Inc LGND.OQ reported quarterly adjusted earnings of $1.27 per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $1.38. The mean expectation of eight analysts for the quarter was for earnings of $1.19 per share. ...Reuters
Thu, Feb 27
CANADA STOCKS-TSX hits near 6-week low as trade tensions rise
TSX ends down 0.8% at 25,128.24Materials group loses 2.1% as gold fallsRBC shares fall 3.6% after earnings reportNine of 10 major sectors end lowerUpdates at market closeBy Ragini Mathur and Fergal Smith TORONTO, Feb 27 (Reuters) - Canada's main stock index fell on Thursday to a near six-week...Reuters
Thu, Feb 27
EMERGING MARKETS-Latam currencies, stocks wobble after Trump reiterates March 4 tariff deadline
Venezuelan bonds lose ground Kurdish militant leader calls for end to conflict with TurkeyPetrobras shares drop after results MSCI Latam FX down 0.6%, stocks off 1% Updates with mid-session tradingBy Lisa Pauline Mattackal and Purvi Agarwal Feb 27 (Reuters) - Emerging markets broadly fell on Thu...Reuters
Thu, Feb 27
LIVE MARKETS-Wall Street ends sharply lower on economic worries
Dow down ~0.5%, S&P 500 falls ~1.6%, Nasdaq sinks nearly ~3%Tech weakest S&P sector; Energy, Financials lead gainersDollar jumps; crude rises >2%; bitcoin dips; gold down >1%US 10-Year Treasury yield edges up to ~4.27%Welcome to the home for real-time coverage of markets brought to you...Reuters
Thu, Feb 27
